1 Division of Endocrinology/Diabetes, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
The metabolic adaptation to fasting in infants with hyperinsulinism was examined to see whether a characteristic abnormality could be found that would aid in the diagnosis of this disorder. Seven infants under 1 year of age with hyperinsulinism were studied; 7 control infants of similar age and 12 children with ketotic hypoglycemia served as contrast groups. At the time of hypoglycemia, four of the seven infants with hyperinsulinism did not have elevated levels of insulin. However, levels of
-hydroxybutyrate were significantly lower in the infants with hyperinsulinism than in the control and ketotic hypoglycemic groups. Levels of free fatty acids were also lower in the infants with hyperinsulinism. Expected levels and normal limits for
-hydroxybutyrate, insulin, and free fatty acids when plasma glucose is below 40 mg/100 ml were estimated by combining the control and ketotic hypoglycemic groups. Using these values as standards, the diagnosis of hyperinsulinism can be made by evaluation of the response to fasting hypoglycemia. The application of this approach is illustrated by three case examples.
This article has been cited by other articles:
![]() |
A. Kelly, R. Tang, S. Becker, and C. A. Stanley Poor Specificity of Low Growth Hormone and Cortisol Levels During Fasting Hypoglycemia for the Diagnoses of Growth Hormone Deficiency and Adrenal Insufficiency Pediatrics, September 1, 2008; 122(3): e522 - e528. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Palladino, M. J. Bennett, and C. A. Stanley Hyperinsulinism in Infancy and Childhood: When an Insulin Level Is Not Always Enough Clin. Chem., February 1, 2008; 54(2): 256 - 263. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. T. Hardy, M. Hernandez-Pampaloni, J. R. Saffer, J. S. Scheuermann, L. M. Ernst, R. Freifelder, H. Zhuang, C. MacMullen, S. Becker, N. S. Adzick, et al. Accuracy of [18F]Fluorodopa Positron Emission Tomography for Diagnosing and Localizing Focal Congenital Hyperinsulinism J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4706 - 4711. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Henwood, A. Kelly, C. MacMullen, P. Bhatia, A. Ganguly, P. S. Thornton, and C. A. Stanley Genotype-Phenotype Correlations in Children with Congenital Hyperinsulinism Due to Recessive Mutations of the Adenosine Triphosphate-Sensitive Potassium Channel Genes J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 789 - 794. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. DUNNE, K. E. COSGROVE, R. M. SHEPHERD, A. AYNSLEY-GREEN, and K. J. LINDLEY Hyperinsulinism in Infancy: From Basic Science to Clinical Disease Physiol Rev, January 1, 2004; 84(1): 239 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Thornton, C. MacMullen, A. Ganguly, E. Ruchelli, L. Steinkrauss, A. Crane, L. Aguilar-Bryan, and C. A. Stanley Clinical and Molecular Characterization of a Dominant Form of Congenital Hyperinsulinism Caused by a Mutation in the High-Affinity Sulfonylurea Receptor Diabetes, September 1, 2003; 52(9): 2403 - 2410. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Stanley Advances in Diagnosis and Treatment of Hyperinsulinism in Infants and Children J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 4857 - 4859. [Full Text] [PDF] |
||||
![]() |
J.M. Hawdon, S. C. Kalhan, M. P. W. Platt, M. Cornblath, J.-M. Saudubray, P. de Lonlay-Debeney, J.-J. Robert, C. A. Stanley, and L. Baker Clinical Features of Neonates with Hyperinsulinism N. Engl. J. Med., August 26, 1999; 341(9): 701 - 702. [Full Text] |
||||
![]() |
P.M. Mathew, J.M. Young, Y.K. Abu-Osba, B.D. Mulhern, S. Hammoudi, J.A. Hamdan, and A.R. Sa'di Persistent Neonatal Hyperinsulinism Clinical Pediatrics, March 1, 1988; 27(3): 148 - 151. [Abstract] [PDF] |
||||